Key statistics
On Tuesday, Anika Therapeutics Inc (ANIK:NSQ) closed at 14.40, -18.21% below its 52-week high of 17.61, set on Mar 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 14.27 |
|---|---|
| High | 14.46 |
| Low | 13.76 |
| Bid | 11.89 |
| Offer | 14.99 |
| Previous close | 14.32 |
| Average volume | 177.96k |
|---|---|
| Shares outstanding | 14.42m |
| Free float | 13.72m |
| P/E (TTM) | 15.20 |
| Market cap | 206.51m USD |
| EPS (TTM) | 0.9419 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
- Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
- Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
- Anika Therapeutics Announces Leadership Transition
- Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
- Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
- Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
